Workshop Report on the Consolidation of our AntiCounterfeiting Position and Development of an Advocacy Strategy on AntiCounterfeiting and Access to medicines

On the 27th and 28th November 2013, AIDS Law Project in conjunction with NEPHAK and KELIN conducted a successful CSOs Workshop. The workshop was supported by UNAIDS and UNDP.

Figure 1 Participants of the workshop on the Consolidatation of an Anti-Counterfeiting Position and Development of an advocacy strategy on Anti-Counterfeiting and Access to medicines held from the Tuesday 26th – Thursday 28th November 2013 at the Maanzoni Lodge, Athi River, Kenya

Figure 1 Participants of the workshop on the Consolidatation of an Anti-Counterfeiting Position and Development of an advocacy strategy on Anti-Counterfeiting and Access to medicines held from the Tuesday 26th – Thursday 28th November 2013 at the Maanzoni Lodge, Athi River, Kenya

The theme of the workshop was ‘To Consolidate our Anti-Counterfeiting Position and Develop an Advocacy Strategy on Anti-Counterfeiting and Access to Medicines’. The workshop was for two days and we had presentations from various experts.

The various participants were selected from amongst the Membership of COAM (Coalition on Access to Medicines), International Organizations working around issues of Access to Medicines, Doctor’s Union, Govt stakeholders, Community Based Organizations and other Civil Society Organizations working around issues of access to medicines.

The workshop report is attached for your guidance. I will just highlight the key items that we were able to accomplish;

1. Participants were able to understand the underlying issues with regards to Intellectual Property and Access to Medicines e.g What is Intellectual Property and the different categories such as trademarks, patents, copyrights etc.

2. Participants got to know the difference between generic vis a vis originator/branded drugs and why generics are and should not be classified as counterfeits. (This has been a huge problem especially in Kenya where many people have come to associate generics with counterfeits)

3. Participants appreciated the fact that The Anti-Counterfeit Act as it is is a barrier to access to medicines with regards to certain sections of the Act.

4. Participants were able to develop an effective advocacy strategy to be adopted for the review process.

Overall the workshop was a success and we would like to thank everyone who availed their time to be present. For those who could not make it, the report is attached for your information.

Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>